Current practices in the management of diabetic nephropathy.
about
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis.Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.Reactive oxygen species promote tubular injury in diabetic nephropathy: The role of the mitochondrial ros-txnip-nlrp3 biological axis.
P2860
Current practices in the management of diabetic nephropathy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current practices in the management of diabetic nephropathy.
@en
type
label
Current practices in the management of diabetic nephropathy.
@en
prefLabel
Current practices in the management of diabetic nephropathy.
@en
P356
P1476
Current practices in the management of diabetic nephropathy
@en
P2093
P304
330-2; quiz 333
P356
10.4997/JRCPE.2013.413
P407
P577
2013-01-01T00:00:00Z